000 | 01475 a2200421 4500 | ||
---|---|---|---|
005 | 20250513151036.0 | ||
264 | 0 | _c19980901 | |
008 | 199809s 0 0 eng d | ||
022 | _a0090-3493 | ||
024 | 7 |
_a10.1097/00003246-199808000-00032 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHarrison, A M | |
245 | 0 | 0 |
_aGastric pH control in critically ill children receiving intravenous ranitidine. _h[electronic resource] |
260 |
_bCritical care medicine _cAug 1998 |
||
300 |
_a1433-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aCritical Illness _xtherapy |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aGastric Juice _xchemistry |
650 | 0 | 4 |
_aHistamine H2 Antagonists _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHydrogen-Ion Concentration |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 | _aIntensive Care Units, Pediatric |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aRanitidine _xadministration & dosage |
650 | 0 | 4 |
_aStomach Ulcer _xetiology |
650 | 0 | 4 |
_aStress, Physiological _xcomplications |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aLugo, R A | |
700 | 1 | _aVernon, D D | |
773 | 0 |
_tCritical care medicine _gvol. 26 _gno. 8 _gp. 1433-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00003246-199808000-00032 _zAvailable from publisher's website |
999 |
_c9675692 _d9675692 |